Related by context. All words. (Click for frequent words.) 57 HBeAg + 56 receptor antagonism 56 salmeterol fluticasone 56 Ziprasidone 56 somatostatin analog 55 Lamotrigine 55 PegIFN RBV 55 Natalizumab 54 tipranavir 54 APTIVUS r 54 DAPT 54 fludarabine cyclophosphamide 54 Teriflunomide 54 EMRG VIO 53 HBeAg negative patients 53 NFV 53 Sustiva efavirenz 53 doxorubicin docetaxel 53 reuptake inhibitor 52 sertraline Zoloft 52 tipifarnib 52 efavirenz EFV 52 MADRS score 52 oral prednisolone 52 tacrolimus ointment 52 Venlafaxine 52 relapsing multiple sclerosis 52 tocilizumab 52 RU EEU EUROPE ASIA 52 QVAR R 52 LGG 52 clomipramine 52 phenelzine 52 desvenlafaxine succinate 52 paricalcitol 52 ziconotide 52 Rotigotine 52 AVENTIS 52 CZP 52 pancreatic enzyme replacement 51 tipranavir r 51 latanoprost 51 CsA 51 anxiolytic 51 leukotriene receptor antagonist 51 darunavir 51 Pegasys plus Copegus 51 Cardiotoxicity 51 venlafaxine Effexor 51 DAS# remission 51 darunavir ritonavir 51 serotonin reuptake inhibitor 51 ISOCOUNTRY3 51 RU EUROPE ASIA EEU 51 #MG TAB * 51 CIMZIA R 51 intravesical chemotherapy 51 citalopram Celexa 51 paroxetine sertraline 51 glatiramer acetate 51 mITT population 51 Atomoxetine 51 Elitek 50 ABVD 50 atazanavir Reyataz 50 RISPERDAL ® 50 NMDA antagonist 50 aurora kinase inhibitor 50 Zenpep 50 Montgomery Åsberg Depression 50 BENICAR 50 INVEGA ® 50 #MG TAB [001] 50 Protease inhibitor 50 Paroxetine 50 sertraline 50 quetiapine 50 BPS IC 50 fluoxetine 50 antiandrogens 50 Ranibizumab 50 virological response 50 Aggrenox ® 50 Febuxostat 50 EXJADE 50 boosted atazanavir 50 QVAR ® 50 RU EUROPE EEU EMRG 50 BEXXAR Therapeutic Regimen 50 peginterferon 50 BENICAR HCT 49 paroxetine Paxil 49 CIMZIA ™ 49 divalproex sodium 49 neuroleptic 49 #MG CAP [002] 49 REYATAZ ® 49 HCV replicon 49 PHARMACEUTICALS INC 49 LAMICTAL 49 BH3 49 ritonavir boosted lopinavir 49 agomelatine 49 Antiretroviral 49 Telintra 49 cilostazol 49 Pharmacologic 49 HCQ 49 tenecteplase 49 Perforomist Inhalation Solution 49 VivaGel TM 49 IRESSA 49 norethindrone 49 biologic DMARD 48 immunoconjugate 48 TAGS PGOV 48 acamprosate 48 Abilify aripiprazole 48 imipramine 48 hydroxamic acid 48 SSRI citalopram 48 HCV polymerase 48 guanfacine extended release 48 donepezil Aricept 48 antithrombotic therapy 48 GROUP THE TREND 48 AVERAGE VOLUME 48 EFFEXOR XR 48 Antiretroviral ARV 48 aldosterone antagonists 48 diabetes mellitus DM 48 Atazanavir 48 Mirtazapine 48 HuMax 48 STOCK RISES 48 L methionine 48 1MG TAB 48 Valdoxan 48 montelukast 48 AGILECT ® 48 nortriptyline 48 BTZ 48 androgen suppression 47 minocycline 47 β blocker 47 Lactobacillus KW 47 Paromomycin IM Injection 47 NSABP B 47 EMRG POL 47 prazosin 47 duloxetine Cymbalta 47 INTELENCE 47 postexposure prophylaxis 47 THERAPEUTICS 47 hematologic abnormalities 47 VASCULAR 47 SHARES OF ARE MOVING 47 clopidogrel Plavix 47 Methylphenidate 47 Chronic Fatigue Syndrome CFS 47 CONTINUES DOWN 47 reboxetine 47 N acetylcysteine 47 idiopathic Parkinson disease 47 Intervention Effectiveness 47 atherosclerotic renal artery stenosis 47 PEY 47 adenoma recurrence 47 FTC TDF 47 SAMe 47 MEVACOR 47 M4N 47 rimonabant #mg 46 Fluoxetine 46 Entecavir 46 Xalatan R 46 anticholinergics 46 tolterodine 46 elvucitabine 46 methotrexate monotherapy 46 PTI CORR 46 SPL# 46 SHARES UP 46 CONTINUES HIGHER 46 Bipolar Mania 46 symptomatology 46 OZG 46 risperidone Risperdal 46 UDCA 46 solifenacin 46 CONTINUES LOWER 46 ANNOUNCES APPOINTMENT OF 46 DIRECTORATE 46 % TECHNICAL UPTREND 46 tapentadol ER 46 GLAXOSMITHKLINE 46 STOCK RISES #.# 46 paclitaxel Taxol R 46 androgen blockade 46 GG genotype 46 antidepressant efficacy 46 pulmonary hypertension PH 46 THE LOWEST BETA 46 Bupropion 46 calcium antagonist 46 desvenlafaxine 46 Selective serotonin reuptake inhibitors 46 natalizumab 46 SSRI SNRI 46 Brief Psychiatric 46 ASCT 46 HLDGS 46 tratamiento 46 parkinson disease 46 MEDICAL SYSTEMS 46 RP ADV 46 adjunctive ABILIFY 46 L. reuteri 46 guanfacine 46 ASTRAZENECA 46 MOVING AVERAGE CROSSOVER ALERT 46 alteplase 46 BRFS 46 RhuDex 46 neuroleptics 46 menstrual migraine 46 CIPN 46 CROSSES PIVOT POINT SUPPORT 46 DE NEMOURS 46 RRMS patients 46 untreated psychosis 46 highly emetogenic chemotherapy 46 electroacupuncture 46 % CI #.#-#.# [001] 45 PANSS scores 45 GSK '# 45 5MG TAB 45 SANOFI 45 SERCA2a 45 SET TO PULLBACK AFTER 45 BREAKS THROUGH SUPPORT 45 DOWNGRADE ALERT WATCH FOR 45 HDRS 45 THIS CAME AS 45 OAB symptoms 45 PHARMACEUTICALS 45 #MG TAB [002] 45 CRME 45 disulfiram 45 DENGUE 45 cholinesterase inhibitor 45 somatostatin analogs 45 antiepileptic medications 45 Lu AA# 45 paliperidone palmitate 45 SHARES CREEPING HIGHER UP 45 MOMENTUM LOOKS TO CONTINUE 45 pyridostigmine 45 DIALYSIS 45 ZENPEP 45 INVEGA SUSTENNA 45 venlafaxine 45 paroxetine 45 Lofexidine 45 CCBT 45 ER CHOP 45 NeuroVax 45 selective serotonin reuptake inhibitor 45 MBCT 45 interpersonal psychotherapy 45 Cladribine tablets 45 valsartan Diovan 45 CCR5 receptor antagonist 45 KAPIDEX 45 qd 45 IVIg 45 anti androgen 45 HIGHER ON #.#X ABOVE 45 GEST 45 Tesmilifene 45 SHARES SLIDING LOWER DOWN 45 donepezil 45 periprocedural 45 cyhoeddus 45 SYNGENTA 44 SHARES DROP 44 CROSSES PIVOT POINT RESISTANCE 44 MoxDuo TM IR 44 transcranial Doppler ultrasound 44 Arixtra ® 44 INCOME TRUST 44 EARNINGS PREVIEW 'S QUARTERLY 44 SET TO REBOUND AFTER 44 dak li 44 ARESTIN ® 44 Overactive Bladder OAB 44 string 0 code3 44 Europees 44 uptake inhibitors SSRIs 44 warfarin sodium 44 mGluR 44 Megace 44 guideline concordant 44 subscale scores 44 NUVEEN 44 1X ABOVE AVERAGE VOLUME 44 Liraglutide Effect 44 iNO 44 postoperative AF 44 DPNP 44 Antisense Therapeutics 44 TMS Therapy 44 MDN #m #.# 44 THE TREND CONTINUES LOWER 44 FALLS BELOW 3 44 LTRA 44 Generalized Anxiety Disorder 44 comorbid anxiety 44 Symptom severity 44 UNDER PRESSURE DOWN 44 postprandial hyperglycemia 44 WEEK HIGH RECENTLY ECLIPSED 44 adenotonsillectomy 44 CALERIE 44 FSAD 44 Comorbidity 44 Arisaph 44 UPTREND CALL REALIZED AS 44 atypical neuroleptics 44 H1 PROFIT 44 PROSHARES ULTRA 44 pemetrexed Alimta 44 oral protease inhibitor 44 Escitalopram 44 topical corticosteroids 44 PTI MIJ 44 YESTERDAY 'S SELLOFF OF 44 THE WINNING STREAK 44 #.#X ABOVE AVERAGE VOLUME 44 SHARES GAIN 44 CAPITAL LTD 44 ORD #P 44 aripiprazole 44 serotonin norepinephrine 44 pramipexole 44 TRADING RANGE BELOW 44 citalopram 44 Rigel Pharma 44 TriRima 44 CONTINUES UP 44 INTERNATIONAL FINANCE 44 Havrix 44 buproprion 44 GILEAD SCIENCES 44 REACHES INITIAL SUPPORT LEVEL 44 cholinesterase inhibitors 44 pregabalin 44 DISTRIBUTION AGREEMENT WITH 44 HEPATITIS 44 YESTERDAY 'S RALLY OF 44 MATURITY 44 acute mania 44 IPTp 43 WATCH FOR CONTINUED GAINS 43 PEG RATIO 43 antidepressive 43 subsyndromal 43 serotonin reuptake inhibition 43 oral anticoagulation 43 STENT 43 DAY PATTERN FOR 43 Declares Dividend Quick Facts 43 CONSTRUCTION MATERIALS 43 TO APPROACH SUPPORT 43 RSY 43 PEDIATRIC 43 WEEK LOW 43 H#N# VACCINE 43 Teva Pharm 43 HYVET 43 antidepressant monotherapy 43 THE ELECTRICAL COMPONENTS 43 selective serotonin 43 nonmetastatic prostate cancer 43 Depressive Disorder 43 neurocognitive deficits 43 MB BCh 43 CEPHALON 43 INTERNATIONAL THE TREND 43 episodic migraine 43 THE TREND CONTINUES UP 43 EÖ 43 PANSS Positive 43 clinically meaningful improvement 43 IIEF 43 Guides FY# Quick Facts 43 PZA 43 XEPLION R 43 THE STEEL INDUSTRY 43 SPILL LOW OF 43 Napo Pharmaceuticals 43 ENTREE GOLD 43 DAYS AGO 43 anticholinergic medication 43 THE TREND CONTINUES DOWN 43 conjugated equine estrogens 43 PREZISTA ™ 43 NTQ 43 systolic hypertension 43 ALISTA 43 concurrent ITP 43 ARE MOVING HIGHER ON 43 THE MOVE LOWER 43 euthymic patients 43 mu opioid 43 AFTER RAISING 43 EARNINGS REVIEW 43 EMPLOYMENT SERVICES INDUSTRY 43 SHARES COULD PULLBACK 43 peginterferon alpha 43 Sumatriptan OS 43 baclofen 43 PHARMACIES 43 rheumatoid factor 43 INTO THE RED 43 euthymic 43 MINING CORP. 43 dose escalation phase 43 intravenous tissue plasminogen 43 ANTICIPATES 43 elective percutaneous coronary 43 PHRM 43 ProVen 43 plasma cortisol 43 SCIT 43 intranasal corticosteroids 43 Insulin Therapy 43 THE TREND CONTINUES HIGHER 43 STEEL INDUSTRY 43 tapentadol IR 43 androgen deprivation 43 FOLLOWING LAST YEAR 43 STOCK TO WATCH 43 E1 CLO 43 Major Depressive Disorder 43 Mimetics 43 Subgroup analyzes 43 CAPITAL INCREASE 43 CORPORATION LTD 43 HA RA 43 TÇ 42 varenicline Chantix 42 divalproex 42 DETECTS BEARISH ENGULFING PATTERN 42 poststroke depression 42 randomized controlled trials RCTs 42 #.# HAS BEGUN 42 tryptophan depletion 42 Randomized controlled 42 Fibromyalgia syndrome 42 HOT STOCK 42 ALTE 42 NEXT SUPPORT LEVEL FOR 42 TRADING RANGE ABOVE 42 ADvTECH 42 alpha 2A adrenoceptor 42 CLOUD COVER PATTERN FOR 42 BREAKS THROUGH RESISTANCE AT 42 ropinirole 42 BARI 42 OFFERS INVESTORS BETTER VALUE 42 VOLUME WATCH FOR PULLBACK 42 Napo Pharma 42 placebo controlled clinical 42 NeuroStar TMS Therapy 42 Sensipar ® 42 Post Exposure Prophylaxis 42 TO APPROACH RESISTANCE AT 42 clinical pharmacology studies 42 MRNA 42 COMPANY LTD 42 RESSOURCES INC. 42 MZO 42 hepatitis B immune globulin 42 ASST 42 VIDAS 42 dual antiplatelet 42 Aripiprazole 42 Clinical Psychopharmacology 42 BANCA 42 NasalFent 42 NEXT RESISTANCE LEVEL FOR 42 Prelox 42 post exposure prophylaxis 42 E2 CLO 42 CRQ 42 serotonergic 42 antidepressant therapy 42 sustained ventricular tachycardia 42 MOVES INTO NEW 42 COGENT 42 EXEL 42 somatization disorder 42 Stage IIIb 42 nonpharmacologic interventions 42 Kaplan Meier analysis 42 SET TO POSSIBLY REBOUND 42 AFTER GAINING #.# 42 Attention-Deficit/Hyperactivity Disorder ADHD 42 serotonin reuptake inhibitors 42 Thrombolysis 42 CDDP 42 glatiramer acetate Copaxone 42 Induction Chemotherapy 42 LEVEL OF CASH 42 # DEL 42 MOLECULAR 42 DOWNTREND SPOTTED IN SHARES 42 Telecom HOLDRS AMEX 42 THER 42 BCNS 42 MDN HCP #m 42 LHRH antagonist 42 MITSUI 42 D Cycloserine 42 AFTER YESTERDAY 'S SELLOFF 42 ISSUANCE OF 42 WEEK LOW SET 42 COMPANY NAME SYMBOL QTR 42 ROCHE 42 HIV Integrase Inhibitor 42 INTEREST FROM 42 TECHNOLOGIES LTD 42 GPi 42 ON SHARES 42 IT REPORTS EARNINGS 42 MDRP 42 prescribed antipsychotic medication 42 Idera Pharmaceuticals Inc 42 lipid lowering drugs 42 L dopa 42 symptomatic hyponatremia 42 CHY 42 OUT IN SHARES 42 antioxidant supplementation 42 IART 42 CPRX 42 APPROVALS 42 yw y 42 BANCORP INC 42 BOOST UP 42 escitalopram 41 PIA XI top 41 Gralise 41 MESI 41 antidepressant pharmacotherapy 41 BIOTECHNOLOGY 41 HF ACTION 41 cluster randomized controlled 41 HCP C2 #m 41 Main Outcome Measure 41 PRAN 41 SENTENCED TO LIFE 41 CORPORATION LIMITED 41 HPA axis 41 'S LOSSES 41 TRANSFERRED 41 SHARES COULD POTENTIALLY PULLBACK 41 EPS ESTIMATES FOR 41 TERM IMPACT 41 Aggressive Drug Evaluation 41 Mindfulness Based Cognitive Therapy 41 WBPA 41 PULLBACK AFTER YESTERDAY 'S 41 HIGH SHARE PRICE TODAY 41 PNES 41 HalcyGen 41 THE HUMAN RESOURCE 41 mga estudyante 41 ABOVE AVERAGE VOLUME 41 THERAPEUTIC 41 PROPERTIES TRUST 41 intrathecal baclofen 41 MSN Sunnex 41 Arch Surg 41 STRAT 41 IMPLANT 41 mab 41 FIRST TRUST 41 adjuvant endocrine therapy 41 5 HTTLPR 41 urinary incontinence UI 41 suicide attempters 41 psychostimulants 41 TRADING RANGE 41 repetitive transcranial magnetic stimulation 41 RELATIVELY HIGH ENTERPRISE VALUE 41 SMARTREND RESEARCH REPORT AVAILABLE 41 ILLEGAL MIGRANTS 41 REPORTED HER 41 interpersonal psychotherapy IPT 41 PFIZER 41 somatoform disorders 41 Lucentis monotherapy 41 ONE WEEK AGO 41 Prezista darunavir 41 DOWNGRADED ONE WEEK AGO 41 buprenorphine naloxone 41 D Sequenced Treatment 41 PANSS 41 RECEIVED HERE TODAY 41 LIFE TECHNOLOGIES 41 hasta los 41 choroidal vasculopathy 41 stellate ganglion block 41 BALT 41 TO EQUITY RATIO 41 oral fumarate 41 EÜ 41 fluoxetine Prozac 41 UPTREND CALL 41 comorbid depression 41 THE DIVERSIFIED REITS INDUSTRY 41 7 DAYS AGO 41 transdermal testosterone 41 NADT 41 INDUSTRY WITH 41 GOES PROFITABLE THIS YEAR 41 psychopharmacologic 41 Schema Therapy 41 bydd yn 41 WILLIS GROUP 41 BlackRock MuniVest Fund 41 Selhub 41 METALS LTD 41 ACCEPT THE 41 Research Diagnostic Criteria 41 CIN3 + 41 Sycrest 41 TECHNOLOGIES CORPORATION 41 HYPERCOM 41 RGEN 41 FIXED INCOME 41 rTMS 41 Ginkgo extract 40 % SINCE DOWNGRADED 40 SAID SELL 40 fibromyalgia syndrome 40 Duloxetine 40 semestre 40 Interpersonal psychotherapy 40 MCDERMOTT INTERNATIONAL 40 atypical antipsychotic medications 40 2MG TAB 40 APPROACHES NEW UPSIDE TARGET 40 alcuni 40 TOPAMAX ® 40 therapy CBT 40 RESOURCES CORP 40 HEALTH SERVICES 40 Petrolia Drilling ASA 40 BONEPWA 40 PESOS 40 nonadherence 40 IMPROVEMENT OF 40 HCP C3 #m 40 VF CORP 40 DAYS AFTER ANNOUNCEMENT SHARES 40 Relapsing remitting 40 THE MARINE INDUSTRY 40 APEX AMI trial 40 Zevalin consolidation 40 MEDW 40 licenza 40 stone formers 40 functional dyspepsia 40 ImmuPharma 40 acute postoperative 40 ROYALTY TRUST 40 HOLDINGS LTD 40 UPSIDE POTENTIAL 40 PROLOGIS 40 IN RETROSPECT SHARES DOWN 40 Vectibix monotherapy 40 PARTNERS LP 40 #a #a [003] 40 AMBIEN CR 40 SHENG 40 BCRX 40 lipid lowering therapy 40 QUARTER FISCAL 40 BOARD APPROVES 40 BPAX 40 triple nucleoside 40 sydd ar 40 CONSULT 40 alexithymia 40 AMERICAN MEDICAL 40 Relora 40 ACCUMULATE 40 B.Pharm 40 CFS ME 40 Prolonged Exposure 40 selective reuptake inhibitors 40 E RATIO 40 ymchwiliad 40 THE SURGERY CENTER 40 NEW SHORT TERM 40 HADS 40 Cognitive behavioral 40 TECHNOLOGY INC 40 AS POSITIVE EARNINGS 40 EPS GROWTH IN 40 TO PUT UP 40 Relieve Depression 40 ONLINE PHARMACY 40 # DEBTORS MOTION TO 40 hyperphosphorylated tau 40 HUSBAND AND 40 Uprima 40 SSRI 40 L DOPA 40 cyhoedd 40 LOW OF 40 e nei 40 CREME 40 Aquapheresis 40 l' unité 40 ICK 40 DYF 40 DCCT 40 DAEWOO SHIPBUILDING 40 IN POSSESSION OF 40 % SELL OFF 40 AUTOMOTIVE RETAIL INDUSTRY 40 EBITDA RATIO 40 SSRIs selective serotonin 40 ACTIVATE 40 MERGER WITH 40 OAQ 40 TO SALES RATIO 40 RESIST 40 GAMMON GOLD 40 antidepressant escitalopram 40 Electroconvulsive therapy 40 MDN PLATE #m 40 TO GO PROFITABLE 40 Stimulation Therapy 40 Interpersonal Psychotherapy 40 adjuvant systemic 39 WAVE SYSTEMS 39 BMC Musculoskeletal Disorders 39 ANNUITY 39 TENET HEALTHCARE 39 AUXL 39 plc LON 39 subscales 39 PERV 39 newsdesk@afxnews.com abr 39 CAPITAL ONE FINANCIAL 39 MOVE DOWN 39 anti TNFs 39 fel y 39 SIMPADICO 39 C#G 39 LIHIR GOLD 39 premenstrual dysphoric disorder PMDD 39 BLOOD TEST 39 Fresenius Med 39 ON BUY SIDE 39 Ar hyn o bryd 39 somatic symptoms 39 LUTS 39 pharmacologic treatments 39 MASTER CHIEF 39 Inc. LCV RA 39 inni 39 Viveta 39 AEZS 39 dos años 39 Fibromyalgia Syndrome 39 Arqule 39 duloxetine 39 yr ydym 39 MILLION FINANCING 39 DEUTSCHLAND 39 cortical stimulation 39 ac mae'n 39 clopidogrel pretreatment 39 PETROLEUM LIMITED 39 Social Phobia 39 MEDICAL INC 39 Lifecycle Pharma 39 amser 39 OF DIAMONDS 39 BULLETIN TYPE Graduation 39 IRX 39 TLCR 39 COMT 39 REALTY INCOME 39 ystyried 39 Salix Pharma 39 FALLS THRU 39 bipolar affective disorder 39 Methadone Maintenance 39 THE SPECIALIZED FINANCE INDUSTRY 39 RELATES TO 39 SALES RATIO 39 luteal phase 39 TUMOR 39 succimer 39 PHELPS DODGE 39 INTL INC 39 PHARMA 39 DSM IV diagnosis 39 CBIT 39 en dit 39 SALES PER SHARE 39 hwn 39 MANAGEMENT TEAM 39 tic severity 39 ST PHOTO DESMOND 39 pharmacologic stress testing 39 selenium supplementation 39 PHARMACEUTICALS LIMITED 39 QuantiFERON R 39 KERX 39 # AR [001] 39 SUGGEST THAT 39 Transcranial Magnetic Stimulation TMS 39 VEH 39 GROU 39 MEd 39 chronic prostatitis chronic 39 CORP. ANNOUNCES 39 naltrexone 39 GROUP LTD 39 quotes nls 39 affective psychosis 39 pharmacologic therapy 39 opioid dependent 39 INDUSTRIES BHD 39 prodromal symptoms 39 YING 39 objectifs 39 oral naltrexone 39 mae'r yn 39 ac mae'r 39 #.#p ▲ [001] 39 TARGET PRICE 39 ESTEEM 39 OSUR 39 CONSTELLATION BRANDS 39 spud #-#-# drlg [002] 39 TRAINING FOR 39 THYROID 39 MOHD 39 MetS 39 cabo 39 PROFIT MARGINS 39 HERTZ GLOBAL 39 INVESTMENT GRADE 39 HCP #m 39 spinal manipulative 39 androgen depletion 39 HCP #m #.# 39 ALXA 39 RCTs 39 HXM 39 aromatase inhibitors AIs 39 cognitive affective 39 BINDING 39 COMMUNICATIONS INC 39 titration phase 39 3 DAY TRADING 39 Arcus Ventures 38 FXF 38 LIBERMAN 38 Sun.Star Cebu Sunnex 38 CHUA 38 INFORMATION SYSTEMS 38 ACTIVE W 38 AFTER LOSS 38 BLV 38 SHUN 38 RESPONSE FROM 38 subthreshold 38 ACCORD Lipid 38 enhanced external counterpulsation 38 BOSTON PROPERTIES 38 TANVIR 38 #.# ENTERS NEW 38 WAIS III 38 CHOICE HOTELS INTERNATIONAL 38 XPF 38 ORD #.#P [001] 38 codi 38 HSCR 38 APEX AMI 38 Meta analyzes 38 spud #-#-# drlg [004] 38 yan ay 38 LIAN 38 flibanserin #mg 38 Shire Plc SHPGY 38 VICL 38 TADS 38 BSRS 38 Holmium 38 DOWN FROM 38 PAPUA NEW GUINEA 38 Guides FY# Update 38 SLAR 38 DRUG COMPANIES 38 datos 38 Panvax 38 MORGAN STANLEY LOWERED ITS 38 UNILEVER 38 BEARISH MOVING AVERAGE CROSSOVER 38 INJECT 38 jrw 38 electroconvulsive shock 38 Gunderson JG 38 'S RALLY 38 ALKS 38 ENTERS NEW 38 bupropion 38 NICE guideline 38 TUMOUR 38 electroconvulsive therapy ECT 38 HGT 38 HEDGE POSITION 38 AUST 'S 38 MDRD 38 BOND ISSUE 38 GPRO 38 ING GROEP NV 38 TEEKAY 38 WARM AND 38 CONCERTA ® 38 SHMR 38 % SHARES SLIDE 38 CONFIDENCE VOTE 38 APPROACHES NEW DOWNSIDE TARGET 38 DIAGNOSTIC 38 IVTA 38 TAH 38 Pfizer maraviroc 38 ANGLOGOLD ASHANTI 38 lipid lowering medications 38 CORINTHIAN COLLEGES 38 #.#ml [002] 38 QoL 38 CAPITAL BHD 38 Flexi Seal R 38 WERE UP 38 PTI LKJ 38 DENS 38 transcranial magnetic stimulation 38 EQUIVALENT 38 BZF 38 VALUATION 38 acute subacute 38 Cognitive Behavioural Therapy 38 Rigel Pharmaceuticals 38 SCOTTS MIRACLE GRO 37 GASTRIC 37 tsx venture 37 electro acupuncture 37 EDUC 37 DHAP 37 GPRD 37 PSAS 37 CLO RP 37 STEP BD 37 Craniosacral Therapy 37 VRTX 37 HAIR LOSS OR 37 THE INFLUENCE OF 37 QID 37 TO FORWARD 37 LMLP 37 HOLDINGS INC 37 Neuromonics Tinnitus Treatment 37 TTH 37 NPTN 37 Cellmid 37 fy mod 37 rale 37 Oxford Nutrascience 37 EMERITUS 37 INVESTMENT GROUP 37 LMHC 37 TC PD 37 DANAHER 37 BMTI 37 HCP C6 #m 37 UNUM GROUP 37 PEDIACARE Infant Dropper Decongestant